Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 8/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 6/20 | 0.31 |
| ▸ | TP53 | P04637 | 5/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27311886 | 0.90 | CCR1 (0.69) | CCR1CHRM2CCR5NR1I2MDM2 | |
| SCHEMBL653813 | 0.84 | CCR1 (0.82) | CCR1CHRM2CCR5NR1I2MDM2 | |
| SCHEMBL13620886 | 0.84 | CCR1 (0.82) | CCR1CHRM2CCR5NR1I2MDM2 | |
| SCHEMBL18895941 | 0.83 | CCR1 (0.53) | CCR1CHRM2CCR5MDM2TP53 | |
| SCHEMBL18895940 | 0.82 | CCR1 (0.52) | CCR1CHRM2CCR5MDM2TP53 | |
| SCHEMBL16312634 | 0.81 | CCR1 (0.51) | CCR1CHRM2CCR5MDM2TP53 | |
| SCHEMBL10287996 | 0.81 | CCR1 (0.49) | CCR1CHRM2CCR5 | |
| SCHEMBL16312670 | 0.80 | CCR1 (0.51) | CCR1CHRM2CCR5MDM2TP53 | |
| SCHEMBL6858189 | 0.79 | CCR1 (0.62) | CCR1NR1I2MDM2TP53 | |
| SCHEMBL15478321 | 0.77 | CCR1 (0.43) | CCR1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663537-B2 | Chemokine receptor antagonists and methods of use | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2017-05-30 | — | — | US | disclosed |